Skip to content

Ultrasound Guided Suprascapular nerve block combined with intra-articular injection of bupivacaine versus ultrasound-guided interscalene nerve block in shoulder arthroscopy.

Ultrasound Guided Suprascapular nerve block combined with intra-articular injection of bupivacaine versus ultrasound-guided interscalene nerve block in shoulder arthroscopy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202308722616710
Enrollment
30
Registered
2023-08-07
Start date
2023-01-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

ultrasound guided interscalene nerve block
Ultrasound Guided Suprascapular nerve block combined with intra articular injection of bupivacaine

Sponsors

Faculty of Medecine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physical status: ASA I and II. Age: between 21 and 60 years old.

Exclusion criteria

Exclusion criteria: Refusal of informed consent for regional anaesthesia. Known Allergy to one of the study drugs. History or evidence of coagulopathy, use of anti-coagulant, anti-platelet therapy, or infection at the injection site. Patients with a history of drug abuse. Patients with a history of upper limb neuronal injury at the same limb of the block. Patients with history of respiratory distress for fear of diaphragmatic paralysis.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the time interval after which there will be a requirement of the first supplemental dose of rescue analgesia (Pethidine 50mg IM) with NRS =4.

Secondary

MeasureTime frame
The secondary outcome is the total dose of pethidine that will be received as rescue analgesia in 1st 24 hours postoperatively, hemodynamics and complications such as nausea, vomiting, and respiratory distress due to diaphragmatic paralysis assessed by chest ultrasound or pneumothorax assessed clinically and by A-P chest X-ray.

Countries

Egypt

Contacts

Public ContactMostafa Mansour

Consultant

mostafa.mansor@med.asu.edu.eg01093322145

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026